5-(oxetan-3-yloxy)pyridine-2-carboxylic acid
|
P628856-100mg
|
≥97% |
1393330-53-4 |
100mg
|
¥ 948.9
|
期货,请咨询 |
阿拉丁 |
potassium trifluoro(oxolan-3-yl)boranuide
|
P628833-5g
|
≥97% |
1391850-45-5 |
5g
|
¥ 13398.9
|
期货,请咨询 |
阿拉丁 |
potassium trifluoro(oxolan-3-yl)boranuide
|
P628833-500mg
|
≥97% |
1391850-45-5 |
500mg
|
¥ 1786.9
|
期货,请咨询 |
阿拉丁 |
potassium trifluoro(oxolan-3-yl)boranuide
|
P628833-250mg
|
≥97% |
1391850-45-5 |
250mg
|
¥ 1073.9
|
期货,请咨询 |
阿拉丁 |
potassium trifluoro(oxolan-3-yl)boranuide
|
P628833-1g
|
≥97% |
1391850-45-5 |
1g
|
¥ 2679.9
|
期货,请咨询 |
阿拉丁 |
potassium trifluoro(oxolan-3-yl)boranuide
|
P628833-100mg
|
≥97% |
1391850-45-5 |
100mg
|
¥ 671.9
|
期货,请咨询 |
阿拉丁 |
1-(p-tolylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine
|
P628780-5g
|
≥97% |
1382358-37-3 |
5g
|
¥ 8426.9
|
期货,请咨询 |
阿拉丁 |
1-(p-tolylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine
|
P628780-500mg
|
≥97% |
1382358-37-3 |
500mg
|
¥ 1245.9
|
期货,请咨询 |
阿拉丁 |
1-(p-tolylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine
|
P628780-250mg
|
≥97% |
1382358-37-3 |
250mg
|
¥ 750.9
|
期货,请咨询 |
阿拉丁 |
1-(p-tolylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine
|
P628780-1g
|
≥97% |
1382358-37-3 |
1g
|
¥ 1879.9
|
期货,请咨询 |
阿拉丁 |
1-(p-tolylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine
|
P628780-10g
|
≥97% |
1382358-37-3 |
10g
|
¥ 16010.9
|
期货,请咨询 |
阿拉丁 |
1-pyrimidin-2-ylcyclopropanecarbonitrile
|
P628742-5g
|
≥97% |
1378798-49-2 |
5g
|
¥ 23920.9
|
期货,请咨询 |
阿拉丁 |
1-pyrimidin-2-ylcyclopropanecarbonitrile
|
P628742-500mg
|
≥97% |
1378798-49-2 |
500mg
|
¥ 3357.9
|
期货,请咨询 |
阿拉丁 |
1-pyrimidin-2-ylcyclopropanecarbonitrile
|
P628742-250mg
|
≥97% |
1378798-49-2 |
250mg
|
¥ 2017.9
|
期货,请咨询 |
阿拉丁 |
1-pyrimidin-2-ylcyclopropanecarbonitrile
|
P628742-1g
|
≥97% |
1378798-49-2 |
1g
|
¥ 5035.9
|
期货,请咨询 |
阿拉丁 |
1-pyrimidin-2-ylcyclopropanecarbonitrile
|
P628742-100mg
|
≥97% |
1378798-49-2 |
100mg
|
¥ 1258.9
|
期货,请咨询 |
阿拉丁 |
(3S)-1-(oxetan-3-yl)pyrrolidin-3-ol
|
P628724-500mg
|
≥97% |
1375415-97-6 |
500mg
|
¥ 4202.9
|
期货,请咨询 |
阿拉丁 |
(3S)-1-(oxetan-3-yl)pyrrolidin-3-ol
|
P628724-250mg
|
≥97% |
1375415-97-6 |
250mg
|
¥ 2519.9
|
期货,请咨询 |
阿拉丁 |
(3S)-1-(oxetan-3-yl)pyrrolidin-3-ol
|
P628724-1g
|
≥97% |
1375415-97-6 |
1g
|
¥ 7563.9
|
期货,请咨询 |
阿拉丁 |
(3S)-1-(oxetan-3-yl)pyrrolidin-3-ol
|
P628724-100mg
|
≥97% |
1375415-97-6 |
100mg
|
¥ 1575.9
|
期货,请咨询 |
阿拉丁 |
4-(3,3-difluoroazetidin-1-yl)piperidine;dihydrochloride
|
P628677-5g
|
≥97% |
1373503-66-2 |
5g
|
¥ 19588.9
|
期货,请咨询 |
阿拉丁 |
4-(3,3-difluoroazetidin-1-yl)piperidine;dihydrochloride
|
P628677-500mg
|
≥97% |
1373503-66-2 |
500mg
|
¥ 2611.9
|
期货,请咨询 |
阿拉丁 |
4-(3,3-difluoroazetidin-1-yl)piperidine;dihydrochloride
|
P628677-250mg
|
≥97% |
1373503-66-2 |
250mg
|
¥ 1568.9
|
期货,请咨询 |
阿拉丁 |
4-(3,3-difluoroazetidin-1-yl)piperidine;dihydrochloride
|
P628677-1g
|
≥97% |
1373503-66-2 |
1g
|
¥ 3918.9
|
期货,请咨询 |
阿拉丁 |